NO20045354L - Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser - Google Patents
Fremgangsmater for behandling av angiogenese, turmorvekst og metastaserInfo
- Publication number
- NO20045354L NO20045354L NO20045354A NO20045354A NO20045354L NO 20045354 L NO20045354 L NO 20045354L NO 20045354 A NO20045354 A NO 20045354A NO 20045354 A NO20045354 A NO 20045354A NO 20045354 L NO20045354 L NO 20045354L
- Authority
- NO
- Norway
- Prior art keywords
- angiogenesis
- metastasis
- treatment
- methods
- tumor growth
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Foreliggende oppfinnelse angår en fremgangsmåte for behandling av kreft eller uønsket angiogenese hos en pasient, som innbefatter administrering av et farmasøytisk preparat innbefattende karbonmonoksid, til pasienten.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US38656102P | 2002-06-05 | 2002-06-05 | |
PCT/US2003/017731 WO2003103585A2 (en) | 2002-06-05 | 2003-06-05 | Methods of treating angiogenesis, tumor growth, and metastasis |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20045354L true NO20045354L (no) | 2004-12-22 |
Family
ID=29736179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045354A NO20045354L (no) | 2002-06-05 | 2004-12-07 | Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser |
Country Status (14)
Country | Link |
---|---|
US (1) | US20040258772A1 (no) |
EP (1) | EP1509237A4 (no) |
JP (1) | JP2005532351A (no) |
CN (1) | CN1674922A (no) |
AU (1) | AU2003248621A1 (no) |
CA (1) | CA2487413A1 (no) |
EA (1) | EA200401622A1 (no) |
HR (1) | HRP20041146A2 (no) |
MX (1) | MXPA04012167A (no) |
NO (1) | NO20045354L (no) |
PL (1) | PL374375A1 (no) |
RS (1) | RS105304A (no) |
UA (1) | UA87438C2 (no) |
WO (1) | WO2003103585A2 (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678390B2 (en) | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
WO2003000114A2 (en) * | 2001-06-21 | 2003-01-03 | Beth Israel Deaconess Medical Center | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
US7011854B2 (en) * | 2002-02-04 | 2006-03-14 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
US8097585B2 (en) | 2002-04-15 | 2012-01-17 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation |
CA2481786A1 (en) | 2002-04-15 | 2003-10-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating necrotizing enterocolitis |
RS91004A (en) | 2002-04-15 | 2007-02-05 | University Of Pittsburgh Of The Commonwealth System Of Higher Education, | Methods of treating ileus |
WO2003096977A2 (en) * | 2002-05-17 | 2003-11-27 | Yale University | Methods of treating hepatitis |
US20040131703A1 (en) * | 2002-06-21 | 2004-07-08 | Bach Fritz H. | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
DE10230165A1 (de) * | 2002-07-04 | 2004-01-15 | Ino Therapeutics Gmbh | Verfahren und Vorrichtung zur Administration von Kohlenmonoxid |
US20100158795A1 (en) * | 2008-06-12 | 2010-06-24 | Pulmonx | Methods and systems for assessing lung function and delivering therapeutic agents |
JP2006514621A (ja) * | 2002-11-07 | 2006-05-11 | ユニバーシティー オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 出血性ショックの治療 |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
EP1675459A1 (en) * | 2003-08-04 | 2006-07-05 | Hemocorm Limited | Use of boranocarbonates for the therapeutic delivery of carbon monoxide |
CN100475275C (zh) * | 2004-01-05 | 2009-04-08 | 董永华 | 肿瘤血管栓塞剂及其储存和释放装置 |
WO2007073226A1 (en) * | 2005-12-20 | 2007-06-28 | Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda | Method for treating a mammal by administration of a compound having the ability to release co |
WO2007073005A1 (ja) * | 2005-12-22 | 2007-06-28 | Keio University | メチル基転移反応調節物質 |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
JP5552262B2 (ja) * | 2009-05-13 | 2014-07-16 | フクダ電子株式会社 | 肺疾患の治療に用いられる気体製剤 |
CN103491783A (zh) | 2011-01-14 | 2014-01-01 | 洛杉矶儿童医院 | 用于治疗包括镰状细胞疾病的疾病的一氧化碳溶液 |
WO2012145520A2 (en) | 2011-04-19 | 2012-10-26 | Alfama, Inc. | Carbon monoxide releasing molecules and uses thereof |
WO2013013179A1 (en) | 2011-07-21 | 2013-01-24 | Alfama, Inc. | Ruthenium carbon monoxide releasing molecules and uses thereof |
JP2014525399A (ja) * | 2011-08-09 | 2014-09-29 | ベス・イスラエル・ディーコネス・メディカル・センター,インコーポレイテッド | Dna損傷を処置する方法 |
JPWO2018225785A1 (ja) * | 2017-06-06 | 2020-04-16 | 株式会社Atomis | ワクチン組成物 |
EP4065074A4 (en) * | 2019-11-25 | 2024-01-03 | Beyond Air, Inc. | SYSTEM AND METHOD FOR DELIVERING GAS TO TISSUE |
WO2022015986A1 (en) * | 2020-07-16 | 2022-01-20 | Cornell University | Methods for treating metastatic cancer using low dose carbon monoxide |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
US4264739A (en) * | 1979-01-05 | 1981-04-28 | Merck & Co., Inc. | Sparger for cell culture system |
US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
US5084380A (en) * | 1985-01-29 | 1992-01-28 | Applied Biotechnology | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
US5449665A (en) * | 1985-09-24 | 1995-09-12 | Item Development Aktiebolag | Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty |
DE3739650C1 (de) * | 1987-11-23 | 1989-05-24 | Immuno Ag | Fermenter zum Zuechten von Zellkulturen |
US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
US5792325A (en) * | 1990-11-15 | 1998-08-11 | Richardson, Jr.; William H. | Electric arc material processing system |
US5293875A (en) * | 1992-06-16 | 1994-03-15 | Natus Medical Incorporated | In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods |
EP0693924B2 (en) * | 1993-02-22 | 2008-04-09 | Abraxis BioScience, Inc. | Methods for (in vivo) delivery of biologics and compositions useful therefor |
US5763431A (en) * | 1993-08-20 | 1998-06-09 | Jackson; Meyer B. | Method for regulating neuropeptide hormone secretion |
DE4421433C1 (de) * | 1994-06-18 | 1995-06-08 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung |
US5476764A (en) * | 1994-09-16 | 1995-12-19 | The Regents Of The University Of California | Method using CO for extending the useful shelf-life of refrigerated red blood cells |
US6066333A (en) * | 1994-09-22 | 2000-05-23 | William Harvey Research Limited | Pharmaceutical control of inflammation |
US5664563A (en) * | 1994-12-09 | 1997-09-09 | Cardiopulmonary Corporation | Pneumatic system |
US5914316A (en) * | 1994-12-16 | 1999-06-22 | Washington University | Method of inhibiting intimal hyperplasia |
US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
FR2735382B1 (fr) * | 1995-06-15 | 1997-07-25 | Air Liquide | Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique |
JP3195363B2 (ja) * | 1995-06-30 | 2001-08-06 | ザイモジェネティクス,インコーポレイティド | Pdgfアンタゴニストとしての4−〔2−(n−2−カルボキサミドインドール)アミノエチル〕ベンゼンスルホンアミドまたはスルホニル尿素 |
CN1208053C (zh) * | 1996-04-05 | 2005-06-29 | 综合医院公司 | 气体氧化氮在制备用于治疗血红蛋白病的冶疗气体中的应用 |
US6069132A (en) * | 1996-08-14 | 2000-05-30 | Revanker; Ganapathi R. | Phosphazole compounds |
US6316403B1 (en) * | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US8128963B2 (en) * | 1996-09-27 | 2012-03-06 | The Trustees Of Columbia University In The City Of New York | Methods for treating ischemic disorders using carbon monoxide |
TR200101501T2 (tr) * | 1998-03-16 | 2002-06-21 | Celgene Corporation | 2-(2,6-dioksopiperidin-3-il)izoindolin türevleri, bunların hazırlanması ve enflamatuar sitokinlerin inhibitörleri olarak kullanımı. |
US6203991B1 (en) * | 1998-08-21 | 2001-03-20 | The Regents Of The University Of Michigan | Inhibition of smooth muscle cell migration by heme oxygenase I |
US7678390B2 (en) * | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
US20050250688A1 (en) * | 1999-04-01 | 2005-11-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
BR0208012A (pt) * | 2001-03-20 | 2004-03-02 | Glaxo Group Ltd | Usos de pelo menos duas drogas e um propelente hfa e de pelo menos uma composição farmaceêutica, e, inalador acondicionado para tratar asma |
IL158182A0 (en) * | 2001-03-30 | 2004-03-28 | Sangstat Medical Corp | Carbon monoxide generating compounds for treatment of vacular, inflammatory and immune disorders |
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
EP1395241B9 (en) * | 2001-05-25 | 2005-06-15 | Medtronic, Inc. | Implantable medical device with controllable gaseous agent release system |
WO2003000114A2 (en) * | 2001-06-21 | 2003-01-03 | Beth Israel Deaconess Medical Center | Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis |
US7069026B2 (en) * | 2001-06-28 | 2006-06-27 | Nokia Corporation | Geographic area assisted system selection for mobile stations |
US7011854B2 (en) * | 2002-02-04 | 2006-03-14 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
AU2003211102B2 (en) * | 2002-02-13 | 2010-03-04 | Beth Israel Deaconess Medical Center, Inc. | Methods of treating vascular disease |
RS91004A (en) * | 2002-04-15 | 2007-02-05 | University Of Pittsburgh Of The Commonwealth System Of Higher Education, | Methods of treating ileus |
CA2481786A1 (en) * | 2002-04-15 | 2003-10-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating necrotizing enterocolitis |
WO2003096977A2 (en) * | 2002-05-17 | 2003-11-27 | Yale University | Methods of treating hepatitis |
US20040131703A1 (en) * | 2002-06-21 | 2004-07-08 | Bach Fritz H. | Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
JP2006514621A (ja) * | 2002-11-07 | 2006-05-11 | ユニバーシティー オブ ピッツバーグ オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション | 出血性ショックの治療 |
-
2003
- 2003-06-05 EA EA200401622A patent/EA200401622A1/ru unknown
- 2003-06-05 PL PL03374375A patent/PL374375A1/xx not_active Application Discontinuation
- 2003-06-05 MX MXPA04012167A patent/MXPA04012167A/es not_active Application Discontinuation
- 2003-06-05 AU AU2003248621A patent/AU2003248621A1/en not_active Abandoned
- 2003-06-05 CN CNA038188724A patent/CN1674922A/zh active Pending
- 2003-06-05 RS YUP-1053/04A patent/RS105304A/sr unknown
- 2003-06-05 EP EP03757348A patent/EP1509237A4/en not_active Withdrawn
- 2003-06-05 US US10/455,564 patent/US20040258772A1/en not_active Abandoned
- 2003-06-05 JP JP2004510706A patent/JP2005532351A/ja active Pending
- 2003-06-05 WO PCT/US2003/017731 patent/WO2003103585A2/en active Application Filing
- 2003-06-05 CA CA002487413A patent/CA2487413A1/en not_active Abandoned
- 2003-06-05 UA UAA200500061A patent/UA87438C2/ru unknown
-
2004
- 2004-12-01 HR HR20041146A patent/HRP20041146A2/xx not_active Application Discontinuation
- 2004-12-07 NO NO20045354A patent/NO20045354L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN1674922A (zh) | 2005-09-28 |
WO2003103585A2 (en) | 2003-12-18 |
RS105304A (en) | 2007-02-05 |
WO2003103585A3 (en) | 2004-08-26 |
EP1509237A2 (en) | 2005-03-02 |
EP1509237A4 (en) | 2006-07-12 |
PL374375A1 (en) | 2005-10-17 |
US20040258772A1 (en) | 2004-12-23 |
AU2003248621A1 (en) | 2003-12-22 |
EA200401622A1 (ru) | 2005-06-30 |
MXPA04012167A (es) | 2005-09-21 |
JP2005532351A (ja) | 2005-10-27 |
UA87438C2 (ru) | 2009-07-27 |
CA2487413A1 (en) | 2003-12-18 |
HRP20041146A2 (en) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20045354L (no) | Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser | |
NO20045056L (no) | Fremgangsmater for behandling av hepatitt | |
DK1373215T3 (da) | Gelanamycinderivater egnet til behandling af cancer | |
RS91004A (en) | Methods of treating ileus | |
NO20071426L (no) | Kreft kombinasjonsbehandling omfattende AZD2171 og Imatinib | |
NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
NO20061325L (no) | Kombinasjon av legemidler for behandling av neoplasmer | |
NO20050607L (no) | Fremgangsmate og innretning for tildeling av CO | |
DE50310516D1 (de) | Fredericamycin-derivate | |
NO20055832L (no) | Fremstilling og anvendelse av arylalkylsyrederivater for behandling av fedme | |
MY169308A (en) | Treatment of tnf? related disorders | |
BRPI0418745A (pt) | anticorpo linhagem de células, composição farmacêutica, e, método de tratamento de cáncer em um paciente | |
WO2004065423A3 (de) | Erkennungsmoleküle zur behandlung und detektion von tumoren | |
HK1087018A1 (en) | Peptide-based passive immunization therapy for treatment of atherosclerosis | |
RS91104A (en) | Methods of treating necrotizing enterocolitis | |
WO2004073615A3 (en) | Deazaflavin compounds and methods of use thereof | |
WO2005081972A3 (en) | Maleiimide anti-tumor phosphatase inhibitors | |
WO2004030607A3 (en) | Peptide-based passive immunization therapy for treatment of atherosclerosis | |
DK1523985T3 (da) | Ikke-radioaktivt strontiumholdigt middel til behandling af kræft | |
BR0316010A (pt) | Combinação | |
ATE407925T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
ATE493144T1 (de) | Zusammensetzung und verfahren zur abtötung von tumoren | |
ATE402147T1 (de) | 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen | |
ATE359789T1 (de) | Verwendung von 4-pyridylmethyl-phthalazin- derivaten zur herstellung eines medikaments zur behandlung von myelodysplastischen syndromen | |
ATE508771T1 (de) | Zytoprotektion durch phosphotyrosin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |